Warner B. Bair

562 total citations
8 papers, 464 citations indexed

About

Warner B. Bair is a scholar working on Molecular Biology, Toxicology and Organic Chemistry. According to data from OpenAlex, Warner B. Bair has authored 8 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Toxicology and 2 papers in Organic Chemistry. Recurrent topics in Warner B. Bair's work include Genomics, phytochemicals, and oxidative stress (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Free Radicals and Antioxidants (2 papers). Warner B. Bair is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Free Radicals and Antioxidants (2 papers). Warner B. Bair collaborates with scholars based in United States, Czechia and Japan. Warner B. Bair's co-authors include Georg T. Wondrak, Christopher M. Cabello, Alexandra S. Bause, Sarah D. Lamore, Stephanie Ley, Kôji Uchida, G. Tim Bowden, Shuxi Qiao, Guangming Liu and David S. Alberts and has published in prestigious journals such as Free Radical Biology and Medicine, Biochemical Pharmacology and Carcinogenesis.

In The Last Decade

Warner B. Bair

8 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Warner B. Bair United States 8 228 55 46 43 41 8 464
Margaret Hanausek United States 14 337 1.5× 37 0.7× 68 1.5× 64 1.5× 16 0.4× 39 636
Fumie Hashimoto Japan 15 288 1.3× 51 0.9× 17 0.4× 16 0.4× 36 0.9× 40 545
Barbara Szachowicz‐Petelska Poland 12 325 1.4× 31 0.6× 63 1.4× 39 0.9× 17 0.4× 25 554
Zhixu Ni Germany 14 401 1.8× 26 0.5× 33 0.7× 10 0.2× 25 0.6× 26 678
Atul Khandwala United States 17 261 1.1× 243 4.4× 51 1.1× 65 1.5× 28 0.7× 47 892
Van‐An Duong South Korea 16 448 2.0× 29 0.5× 24 0.5× 83 1.9× 18 0.4× 36 964
Takayuki Kumano Japan 10 178 0.8× 43 0.8× 22 0.5× 69 1.6× 12 0.3× 16 456
Rebecca L. Edwards United States 10 297 1.3× 58 1.1× 21 0.5× 22 0.5× 45 1.1× 15 858
Waseem El‐Huneidi United Arab Emirates 15 257 1.1× 59 1.1× 93 2.0× 41 1.0× 8 0.2× 61 653
Nobufusa Serizawa Japan 17 678 3.0× 96 1.7× 22 0.5× 60 1.4× 11 0.3× 55 1.1k

Countries citing papers authored by Warner B. Bair

Since Specialization
Citations

This map shows the geographic impact of Warner B. Bair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warner B. Bair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warner B. Bair more than expected).

Fields of papers citing papers by Warner B. Bair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warner B. Bair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warner B. Bair. The network helps show where Warner B. Bair may publish in the future.

Co-authorship network of co-authors of Warner B. Bair

This figure shows the co-authorship network connecting the top 25 collaborators of Warner B. Bair. A scholar is included among the top collaborators of Warner B. Bair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warner B. Bair. Warner B. Bair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Cabello, Christopher M., et al.. (2011). The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis. Investigational New Drugs. 30(4). 1289–1301. 67 indexed citations
2.
Cabello, Christopher M., et al.. (2010). DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma. Free Radical Research. 45(3). 276–292. 12 indexed citations
3.
Bair, Warner B., Christopher M. Cabello, Kôji Uchida, Alexandra S. Bause, & Georg T. Wondrak. (2010). GLO1 overexpression in human malignant melanoma. Melanoma Research. 20(2). 85–96. 78 indexed citations
4.
Cabello, Christopher M., Warner B. Bair, Alexandra S. Bause, & Georg T. Wondrak. (2009). Antimelanoma activity of the redox dye DCPIP (2,6-dichlorophenolindophenol) is antagonized by NQO1. Biochemical Pharmacology. 78(4). 344–354. 33 indexed citations
6.
Cabello, Christopher M., Warner B. Bair, Sarah D. Lamore, et al.. (2008). The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth. Free Radical Biology and Medicine. 46(2). 220–231. 166 indexed citations
7.
Bair, Warner B., Janine G. Einspahr, Guangming Liu, et al.. (2002). Inhibitory effects of sodium salicylate and acetylsalicylic acid on UVB-induced mouse skin carcinogenesis.. PubMed. 11(12). 1645–52. 38 indexed citations
8.
Edmonds, Andrew, et al.. (1999). Inhibitory effects of deferoxamine on UVB-induced AP-1 transactivation. Carcinogenesis. 20(11). 2137–2142. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026